Abu Dhabi, 10 March 2025: Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic Progenitor Cell Collection. This achievement marks ADSCC and Yas Clinic as the first to earn this accreditation in the UAE, and the second in the Middle East and North Africa region (MENA), meeting the highest standards of quality and safety in in the procurement, processing, and storage of hematopoietic progenitor cells, which are critical for transplantation and treating various blood disorders and autoimmune diseases.
As a Centre of Excellence in Hematopoietic Stem Cell Transplantation, accredited by the Department of Health Abu Dhabi and an accredited facility by the Foundation of Accreditation for Cellular Therapy (FACT), ADSCC and Yas Clinic’s AABB accreditation further reinforces their commitment to excellence in cellular therapy and solidifies their leadership in regenerative medicine. Earning these three accreditations for cellular therapies in only 24 months is a testament to their dedication to the highest standards of quality, safety, and innovation in patient care within their Abu Dhabi Bone Marrow Transplant Program and their fully-fledged CAR-T and Mesenchymal Stem Cells programmes.
Prof Yendry Ventura, Chief Executive Officer of ADSCC and Adjunct Professor at United Arab Emirates University, said: “Under the visionary leadership of the UAE and in alignment with the national healthcare agenda, ADSCC and Yas Clinic remain dedicated to advancing cellular therapy and medical innovation on a global scale. Achieving AABB accreditation marks a significant milestone in our commitment to excellence in cellular therapies. As the first institution in the UAE to receive this prestigious accreditation, we continue to set new benchmarks in quality and patient safety which is backed by a solid infrastructure, a state-of-the-art apheresis and ECP unit, and unparalleled clinical expertise. This achievement underscores our dedication to pioneering cutting-edge treatments, enhancing healthcare standards, and reinforcing UAE’s position as a regional leader in regenerative medicine and biological sciences.”
Dr Maysoon Al Karam, Chief Medical Officer at Yas Clinic operated by ADSCC, said: “This achievement reflects the efforts and expertise of our entire team of scientists, haematologists, immunologists, nurses and technicians and beyond. Being one of only two AABB-accredited facilities in the MENA region for HPC collection is a significant milestone for our patients and also physicians, and we are proud to contribute to the advancement of cellular therapy in the UAE and beyond. This accreditation positions ADSCC and Yas Clinic as a regional leader in bone marrow transplant and cellular therapy and reinforces our role in providing cutting-edge treatments to patients.”
AABB’s accreditation programme is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field. AABB’s accreditation programme promotes the highest standards of care for patients, donors, processes and products in all aspects of transfusion medicine, biotherapies and relationship testing.
RSS Feed 
